“Human Th17 Cells Express High Levels of Enzymatically active Dipeptidylpeptidase IV (CD26)”
Bengsch B, R Thimme, et al, (2012) J Immunol 188(11): 5438-5447.
In transwell assays, CD26(bright) Th17 cells inhibited chemotaxis of CXCR4+ Th1 T cells towards CXCL12.
CD26 appears to be an interesting and useful marker for Th17 autoimmunity.
Ancell anti-CD26 reagents (clone 202.36):